Fluorofenidone Inhibits the Proliferation of Lung Adenocarcinoma Cells

Background: Lung carcinoma is the leading cause of malignant tumor related mortality in China in recent decades, and the development of new and effective therapies for patients with advanced lung carcinoma is needed. We recently found that fluorofenidone (FD), a newly developed pyridine compound, re...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Zheng-hao, Meng, Jie, Tang, Juan, Hu, Gao-yun, Tao, Li-jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556656/
https://www.ncbi.nlm.nih.gov/pubmed/28819390
http://dx.doi.org/10.7150/jca.18040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5556656/
https://www.ncbi.nlm.nih.gov/pubmed/28819390
http://dx.doi.org/10.7150/jca.18040

Ejemplares similares